# No indications of weight gain associated DNA methylation changes in patients with anorexia nervosa

**Authors:** Luisa Sophie Rajcsanyi, Miriam Kesselmeier, Christopher Schröder, Carolin Schmelting, Triinu Peters, Manuel Föcker, Isabelle Kraft, Jasmin Beygo, Elsa Leitão, Michael Zeschnigk, Johanna Giuranna, Beate Herpertz-Dahlmann, Jochen Seitz, Martina de Zwaan, Wolfgang Herzog, Stefan Ehrlich, Stephan Zipfel, Katrin Giel, Karin Egberts, Roland Burghardt, Bettina Budeus, Johannes Hebebrand, Bernhard Horsthemke, Anke Hinney

PMC · DOI: 10.1038/s41598-025-12592-5 · Scientific Reports · 2025-08-07

## TL;DR

This study found no evidence of DNA methylation changes linked to weight gain in patients with anorexia nervosa.

## Contribution

The study replicates and investigates DNA methylation changes in anorexia nervosa patients during weight gain, finding no significant results.

## Key findings

- No hypomethylation was observed at the NR1H3 gene locus in anorexia nervosa patients.
- Subtle methylation differences were detected only when lowering analysis thresholds, but not confirmed in replication.
- No methylation differences were detected between admission and discharge in anorexia nervosa patients.

## Abstract

Anorexia nervosa (AN) is a mental disorder marked by a significantly low body weight. Differentially methylated CpG sites have been reported to be involved in body weight regulation. Methylation pattern may change during considerable weight gain by in-patient treatment. Consequently, we aimed to (1) replicate the hypomethylation at the NR1H3 gene locus (identified in our previous epigenome-wide association study) in independent study groups of 189 female patients with AN and 67 healthy-lean female controls, and (2) identify regions associated with large weight gain associated DNA methylation changes in three patients with AN through whole-genome bisulfite sequencing in CD14+ cells. In the replication study, no evidence was observed for hypomethylation at the investigated 15 CpG sites of the NR1H3 locus. Relying on two analysis tools (camel, metilene) to identify differentially methylated regions (DMRs), subtle methylation differences concordant between both tools were detected only when the usual threshold of camel was lowered. Then, eight regions were selected exemplarily for technical replication with deep bisulfite sequencing in the same three patients with AN. None of the regions could be confirmed. Summarising, we could not confirm hypomethylation at NR1H3 and could not detect methylation differences in patients with AN between admission and weight gain at discharge.

The online version contains supplementary material available at 10.1038/s41598-025-12592-5.

## Linked entities

- **Genes:** NR1H3 (nuclear receptor subfamily 1 group H member 3) [NCBI Gene 10062]
- **Diseases:** anorexia nervosa (MONDO:0005351)

## Full-text entities

- **Genes:** CD14 (CD14 molecule) [NCBI Gene 929], NR1H3 (nuclear receptor subfamily 1 group H member 3) [NCBI Gene 10062] {aka LXR-a, LXRA, RLD-1}
- **Diseases:** mental disorder (MESH:D001523), weight gain (MESH:D015430), AN (MESH:D000856)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12331989/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12331989/full.md

## References

5 references — full list in the complete paper: https://tomesphere.com/paper/PMC12331989/full.md

---
Source: https://tomesphere.com/paper/PMC12331989